Xeris Biopharma (XERS) Financials: Revenue & Earnings

XERS price $10.65 +0.20 +1.96%

Ticker
XERS
Price
$10.65
Change
+0.20 +1.96%
Market cap ?
$1.94B
P/E ?
-105.15
Forward P/E ?
2131.00
Dividend yield ?
0.00%
Beta ?
0.84
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
65
Value
32
Quality
70
Growth
94

Stocklytics score rationale: value 32, quality 70, growth 94.

Financials

2016201720182019202020212022202320242025
10750001556000246500027220002043500049590000110248000163914000203070000291845000

Xeris Biopharma Holdings, Inc. operates as a biopharmaceutical company, focusing on the development and commercialization of therapeutic solutions for individuals across the fields of endocrinology, neurology, and gastroenterology. Its current portfolio includes: Gvoke: A ready-to-administer liquid glucagon designed to treat severe hypoglycemia. Keveyis: A therapy addressing hyperkalemic, hypokalemic, and related…

Fair value

XERS fair value $15.84. Price $10.65. Price is 33% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare XERS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—0.03—101.68M
2026-08-06-0.180.0191.00M90.12M
2026-05-070.01-0.0082.45M79.83M
2026-03-020.060.0385.81M82.20M
2025-11-060.000.0174.38M86.00M
2025-08-07-0.01-0.0371.54M72.25M
2025-05-08-0.06-0.0760.12M57.61M
2025-03-06-0.03-0.0860.10M54.90M
2024-11-08-0.06-0.0952.86M51.45M
2024-08-08-0.10-0.1148.06M45.81M
2024-05-09-0.14-0.1240.64M41.81M
2024-03-06-0.10-0.0944.39M45.81M
2023-11-09-0.09-0.1248.32M42.70M
2023-08-08-0.14-0.1338.01M35.16M
2023-05-09-0.12-0.1733.20M31.03M
2023-03-08-0.10-0.1633.14M30.96M
2022-11-09-0.14-0.1729.73M29.04M
2022-08-10-0.19-0.2325.31M41.08M
2022-05-11-0.25-0.2422.07M23.39M
2022-03-10-0.42-0.2121.43M18.97M
2021-11-10-0.36-0.3711.04M11.01M
2021-08-05-0.41-0.318.91M8.91M
2021-05-13-0.30-0.318.05M9.00M
2021-03-09-0.41-0.397.09M—
2020-11-09-0.35-0.549.45M12.54M
2020-08-10-0.63-0.712.03M2.35M
2020-05-07-0.89-0.921.79M1.79M
2020-03-11-1.23-1.241.86M1.68M
2019-11-07-1.22-1.26323.00K325.65K
2019-08-06-1.28-0.97320.00K235.00K
2019-05-09-1.07-0.83248.00K176.15K
2019-03-06-0.98-1.04801.00K760.13K
2018-11-07-0.71-0.84582.00K639.38K
2018-08-13-3.07-0.88819.00K1.10M
2018-06-21-4.43—467.00K—
2018-03-31-5.49—263.00K—
2017-09-30-3.72—170.00K—
2017-06-30-2.59—565.00K—
2017-03-31-2.29—354.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Pieper StevenSell5.00K$9.4147.04K
2026-10-01McCulloch KevinSell15.00K$9.41141.12K
2026-10-01Hecht BethSell16.67K$9.41156.79K
2026-09-28McCulloch KevinSell25.00K$10.00250.00K
2026-09-01McCulloch KevinSell15.00K$8.49127.31K
2026-09-01Hecht BethSell16.67K$8.49141.43K
2026-09-01Pieper StevenSell5.00K$8.5042.50K
2026-08-12Pieper StevenSell5.00K$8.5042.50K
2026-08-03McCulloch KevinSell15.00K$8.02120.24K
2026-08-03Hecht BethSell16.67K$8.01133.55K
2026-08-01Shannon John Patrick JrSell36.65K$8.08296.09K
2026-08-01McCulloch KevinSell21.92K$8.08177.10K
2026-07-07Pieper StevenSell27.60K$8.52235.28K
2026-07-06Pieper StevenSell17.40K$8.50147.90K
2026-07-01KREHER NERISSABuy37.91K$8.00303.28K
2026-07-01KREHER NERISSABuy33.58K——
2026-07-01KREHER NERISSAOther0——
2026-07-01McCulloch KevinSell90.00K$8.03722.51K
2026-07-01Hecht BethSell16.67K$8.03133.86K
2026-06-04Kong GarhengBuy24.19K——
2026-06-04Kong GarhengBuy33.00K$6.15202.93K
2026-06-04PERSKY MARLABuy24.19K——
2026-06-04PERSKY MARLABuy33.00K$6.15202.93K
2026-06-04HALKUFF DAWNBuy24.19K——
2026-06-04HALKUFF DAWNSell20.00K$6.09121.89K
2026-06-04HALKUFF DAWNBuy33.00K$6.15202.93K
2026-06-04BORMANN-KENNEDY BARBARA-JEAN ANNEBuy24.19K——
2026-06-04BORMANN-KENNEDY BARBARA-JEAN ANNESell16.00K$6.0997.51K
2026-06-04BORMANN-KENNEDY BARBARA-JEAN ANNEBuy33.00K$6.15202.93K
2026-06-04JOHNSON JOHNBuy24.19K——
2026-06-04JOHNSON JOHNSell15.00K$6.0991.42K
2026-06-04JOHNSON JOHNBuy33.00K$6.15202.93K
2026-06-04Brady James AloysiusBuy24.19K——
2026-06-04Brady James AloysiusBuy33.00K$6.15202.93K
2026-06-03PERSKY MARLASell15.50K$5.9091.43K
2026-06-01Hecht BethSell16.67K$6.06100.98K
2026-05-01Hecht BethSell16.67K$6.23103.81K
2026-04-01Hecht BethSell16.67K$5.9999.86K
2026-03-30Brady James AloysiusSell10.83K$5.5460.04K
2026-03-12McCulloch KevinBuy4$3.9416
2026-03-12McCulloch KevinBuy48.89K$4.09199.98K
2026-03-12McCulloch KevinSell4$3.9416
2026-03-12McCulloch KevinSell48.89K$4.09199.98K
2026-03-05Pieper StevenBuy14.04K$5.9383.23K
2026-03-05Pieper StevenBuy27.89K$4.09114.07K
2026-03-05Pieper StevenSell27.89K$4.09114.07K
2026-03-05Pieper StevenSell14.04K$5.9383.23K
2026-03-02Hecht BethSell16.57K$6.24103.38K
2026-03-02Hecht BethSell100$7.06706
2026-02-24Nguyen Anh TuSell29.30K$6.88201.58K
2026-02-02Hecht BethSell16.67K$7.45124.15K
2026-01-31Shannon John Patrick JrSell118.13K$7.36869.47K
2026-01-31Shannon John Patrick JrSell111.62K$7.36821.53K
2026-01-31Shannon John Patrick JrSell110.75K$7.36815.12K
2026-01-31McCulloch KevinSell68.45K$7.36503.82K
2026-01-31McCulloch KevinSell30.29K$7.36222.93K
2026-01-31McCulloch KevinSell27.32K$7.36201.07K
2026-01-31Pieper StevenSell111.77K$7.36822.59K
2026-01-31Pieper StevenSell66.45K$7.36489.07K
2026-01-31Pieper StevenSell27.32K$7.36201.07K
2026-01-31Hecht BethSell98.38K$7.36724.04K
2026-01-31Hecht BethSell46.91K$7.36345.29K
2026-01-31Hecht BethSell24.27K$7.36178.60K
2026-01-30Shannon John Patrick JrBuy478.44K——
2026-01-30Shannon John Patrick JrBuy639.64K$7.364.71M
2026-01-30McCulloch KevinBuy168.46K——
2026-01-30McCulloch KevinBuy225.22K$7.361.66M
2026-01-30Pieper StevenBuy154.99K——
2026-01-30Pieper StevenBuy207.21K$7.361.53M
2026-01-30Nguyen Anh TuBuy121.29K——
2026-01-30Nguyen Anh TuBuy162.16K$7.361.19M
2026-01-30Hecht BethBuy121.29K——
2026-01-30Hecht BethBuy162.16K$7.361.19M
2026-01-08McCulloch KevinSell15.00K$8.00120.00K
2026-01-05Shannon John Patrick JrBuy2.90K$3.9411.43K
2026-01-05Shannon John Patrick JrBuy25.14K$1.5538.96K
2026-01-05Shannon John Patrick JrBuy64.27K$1.5599.61K
2026-01-05Shannon John Patrick JrSell24.91K$7.08176.26K
2026-01-05Shannon John Patrick JrSell2.90K$3.9411.43K
2026-01-05Shannon John Patrick JrSell25.14K$1.5538.96K
2026-01-02Hecht BethSell16.67K$7.43123.78K
2025-12-19JOHNSON JOHNSell135.40K$7.22977.02K
2025-12-12BORMANN-KENNEDY BARBARA-JEAN ANNESell15.00K$7.09106.41K
2025-12-01Hecht BethSell16.67K$7.01116.78K
2025-11-14Shannon John Patrick JrBuy87.10K$1.55135.00K
2025-11-14Shannon John Patrick JrSell87.10K$1.55135.00K
2025-11-13Shannon John Patrick JrBuy8.97K$1.5513.90K
2025-11-13Shannon John Patrick JrSell23.24K$7.46173.40K
2025-11-13Shannon John Patrick JrSell8.97K$1.5513.90K
2025-11-11Hecht BethSell16.67K$7.40123.30K
2025-10-02McCulloch KevinSell733$8.316.09K
2025-09-11McCulloch KevinSell2.00K——
2025-09-11PERSKY MARLASell15.50K$7.72119.61K
2025-08-28SHERMAN JEFFREY WBuy47.04K$6.66313.29K
2025-08-28SHERMAN JEFFREY WSell42.23K$7.92334.52K
2025-08-28SHERMAN JEFFREY WSell47.04K$6.66313.29K
2025-08-13JOHNSON JOHNSell107.50K$7.32786.46K
2025-08-12HALKUFF DAWNSell42.50K$7.28309.23K
2025-08-01Shannon John Patrick JrSell36.92K$5.38198.62K
2025-08-01McCulloch KevinSell14.65K$5.3878.82K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 251, holders +7 vs prior quarter. Ownership 63.50%.

HolderSharesChangeChange %Value
BLACKROCK, INC.14.53M1.58M+12.20%115.04M
D. E. SHAW & CO., INC.7.80M15.95K+0.20%61.81M
VANGUARD CAPITAL MANAGEMENT LLC7.34M359.35K+5.15%58.13M
STATE STREET CORP4.82M163.39K+3.51%38.19M
GEODE CAPITAL MANAGEMENT, LLC4.72M427.55K+9.96%37.37M
NUVEEN, LLC4.39M1.47M+50.35%34.73M
ROSALIND ADVISORS, INC.2.91M-322.72K-9.99%23.04M
QUBE RESEARCH & TECHNOLOGIES LTD2.89M-1.22M-29.67%22.92M
VANGUARD PORTFOLIO MANAGEMENT LLC2.63M-39.40K-1.48%20.80M
WELLINGTON MANAGEMENT GROUP LLP2.37M193.75K+8.92%18.73M
MORGAN STANLEY2.34M-235.56K-9.16%18.51M
LEGAL & GENERAL GROUP PLC2.01M104.50K+5.48%15.94M
ARMISTICE CAPITAL, LLC1.96M48.86K+2.56%15.51M
TWO SIGMA INVESTMENTS, LP1.89M-38.70K-2.01%14.93M
PARKMAN HEALTHCARE PARTNERS LLC1.81M86.36K+5.02%14.32M
ALGERT GLOBAL LLC1.74M585.98K+50.65%13.80M
NORTHERN TRUST CORP1.60M153.13K+10.60%12.65M
GOLDMAN SACHS GROUP INC1.59M-19.58K-1.21%12.63M
AQR CAPITAL MANAGEMENT LLC1.54M146.61K+10.51%12.20M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.49M132.71K+9.76%11.82M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.49M1.49MNew11.82M
FEDERATED HERMES, INC.1.43M577.62K+67.41%11.36M
BANK OF AMERICA CORP /DE/1.40M522.65K+59.77%11.06M
UBS GROUP AG1.30M-345.46K-20.98%10.30M
ISHARA INVESTMENTS LP1.23M205.00K+20.00%9.74M

Earnings and financials

Xeris Biopharma Holdings, Inc. (XERS) trades at $10.65, with a market cap of $1.94B and a trailing P/E of -105.15. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
10750001556000246500027220002043500049590000110248000163914000203070000291845000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Xeris Biopharma (XERS) Financials: Revenue & Earnings

XERS$10.65+0.20 +1.96%

$1.94B

Market Cap

-105.15

P/E

2131.00

Forward P/E

65

Score

Price History